Back | Next |
home / stock / pbsv / pbsv message board
Subject | By | Source | When |
---|---|---|---|
A share buyback would be nice. | MikeDDKing | investorshub | 01/30/2013 2:24:59 AM |
They're doing a nice job of buidling cash | littlefish | investorshub | 01/30/2013 2:14:53 AM |
This company remains drastically undervalued IMO. | MikeDDKing | investorshub | 01/30/2013 2:12:08 AM |
About $8.1 mill in revs for Q4 I | littlefish | investorshub | 01/30/2013 2:10:50 AM |
The trailing PE is now a little over | MikeDDKing | investorshub | 06/15/2012 1:41:35 PM |
$PBSV reported Q1 revenue of $6.360M and diluted | MikeDDKing | investorshub | 03/16/2012 7:18:34 PM |
$PBSV was mentioned in a Seeking Alpha article: | MikeDDKing | investorshub | 03/13/2012 8:53:10 PM |
They haven't put out PRs as long as | MikeDDKing | investorshub | 01/31/2012 4:32:05 PM |
Good report, but no PR to help. | John Bates | investorshub | 01/31/2012 4:31:16 PM |
The 10-K is out. Q4 revenue was | MikeDDKing | investorshub | 01/31/2012 2:24:57 PM |
Oh gee. Illiquidity or not, Zero point | John Bates | investorshub | 01/20/2012 4:35:41 PM |
Illiquidity is always a concern for me but | MikeDDKing | investorshub | 01/19/2012 11:50:13 PM |
Mike, | FrankLind | investorshub | 01/19/2012 11:36:29 PM |
Read this on the Swing Trade Board - | Bucks4Buckeyes | investorshub | 12/07/2011 4:04:55 AM |
$PBSV is one of my favorites which I | MikeDDKing | investorshub | 12/07/2011 2:51:40 AM |
There is a 50K share bid at $0.60 | MikeDDKing | investorshub | 09/15/2011 2:27:19 PM |
Here is a link to the filing: | MikeDDKing | investorshub | 09/15/2011 1:34:46 PM |
$PBSV reports a blowout quarter with revenue of | MikeDDKing | investorshub | 09/15/2011 1:33:35 PM |
The volume on $PBSV is almost 10x the | MikeDDKing | investorshub | 06/28/2011 7:40:49 PM |
$PBSV is one of my favorites and I | MikeDDKing | investorshub | 06/17/2011 4:44:44 PM |
News, Short Squeeze, Breakout and More Instantly...
DORADO, PUERTO RICO / ACCESSWIRE / March 18, 2024 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, chemical, medical device, cos...
Tredegar Corporation (TG) is expected to report for quarter end 2023-12-31 Pharma-Bio Serv Inc (PBSV) is expected to report $0.02 for Q1 2024 Telos Corporation (TLS) is expected to report $-0.18 for Q4 2023 Coretec Group Inc (CRTG) is expected to report for quarter end 2023-12-31 ...
G6 Materials Corp. (GPHBF) is expected to report for quarter end 2023-11-30 High Tide Inc. (HITI) is expected to report $-0.03 for Q4 2023 ServisFirst Bancshares Inc. (SFBS) is expected to report $0.87 for Q4 2023 Sanmina Corporation (SANM) is expected to report $1.05 for Q1 2024 ...